NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $199,438,000 | +16.6% | 5,575,593 | -15.2% | 0.08% | +8.3% |
| Q3 2014 | $170,995,000 | -10.6% | 6,576,759 | +13.7% | 0.07% | -8.9% |
| Q2 2014 | $191,166,000 | +81.6% | 5,784,104 | +64.4% | 0.08% | +75.6% |
| Q1 2014 | $105,286,000 | +75.0% | 3,517,722 | +77.6% | 0.04% | +73.1% |
| Q4 2013 | $60,150,000 | +101.2% | 1,981,190 | +110.9% | 0.03% | +85.7% |
| Q3 2013 | $29,889,000 | +69.3% | 939,615 | -19.6% | 0.01% | +55.6% |
| Q2 2013 | $17,654,000 | – | 1,168,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|